Clinical Trial

Comprehensive Genomic Analysis in Tissue Samples From Patients With Recurrent or Stage IV Non-small Cell Lung Cancer

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This research trial studies comprehensive genomic analysis in tissue samples from patients with non-small cell lung cancer that has come back or is stage IV. Comprehensive genomic analysis may identify specific gene mutations (changes in deoxyribonucleic acid \[DNA\]) and help doctors to tailor treatment to target the specific mutations.
Protocol Amendment History 2 changes
critical Enrollment closed, study ongoing 2026-07-30
notable Enrollment reduced: 1020 -> 619 participants 2026-07-30
Trial Details
NCT Number NCT02178163
Lead Sponsor Barbara Ann Karmanos Cancer Institute
Collaborators: National Cancer Institute (NCI)
Conditions Recurrent Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
Enrollment 619 participants
Start Date 2014-08-01
Primary Completion 2027-07 (estimated)
Study Completion 2027-07 (estimated)
Updated on ClinicalTrials.gov 2026-07-29